Healthcare expenditures of older patients with AML are similar between HMA and intensive induction chemotherapy

Acute myeloid leukemia (AML) is a clonal disorder of hematopoiesis with an aggressive clinical course. In 2017, there were an estimated 21,380 AML diagnoses, at a median age of 68 years [1]. Patien...